世界の経口糖尿病治療薬市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)

GlobalInfoResearchが発行した調査報告書(GIR21JY00001)
◆英語タイトル:Global Oral Antidiabetic Agents Market 2021 by Company, Regions, Type and Application, Forecast to 2026
◆商品コード:GIR21JY00001
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2021年7月
◆ページ数:109
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥396,720見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥595,080見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥793,440見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

GlobalInfoResearch社の本調査レポートでは、経口糖尿病治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。経口糖尿病治療薬の種類別市場規模(スルホニル尿素剤、メグリチニド、ビグアニド、チアゾリジンジオン、α-グルコシダーゼ阻害剤)、用途別市場規模(家庭用、医療機関、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Novo Nordisk、Eli Lilly、Sanofi、Roche、Teva、AstraZeneca、Wockhardt UK、Merck、Pfizer、Cipla
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:スルホニル尿素剤、メグリチニド、ビグアニド、チアゾリジンジオン、α-グルコシダーゼ阻害剤
・用途別分析2016年-2026年:家庭用、医療機関、その他
・経口糖尿病治療薬の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・経口糖尿病治療薬のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・経口糖尿病治療薬のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・経口糖尿病治療薬の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・経口糖尿病治療薬の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Oral Antidiabetic Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Oral Antidiabetic Agents size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Oral Antidiabetic Agents market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Oral Antidiabetic Agents market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Sulfonylureas
Meglitinides
Biguanides
Thiazolidinediones
Alpha-glucosidase Inhibitors

Market segment by Application, can be divided into
Home Use
Medical Institutions
Others

Market segment by players, this report covers
Novo Nordisk
Eli Lilly
Sanofi
Roche
Teva
AstraZeneca
Wockhardt UK
Merck
Pfizer
Cipla

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

【レポートの目次】

1 Market Overview
1.1 Product Overview and Scope of Oral Antidiabetic Agents
1.2 Classification of Oral Antidiabetic Agents by Type
1.2.1 Overview: Global Oral Antidiabetic Agents Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Oral Antidiabetic Agents Revenue Market Share by Type in 2020
1.2.3 Sulfonylureas
1.2.4 Meglitinides
1.2.5 Biguanides
1.2.6 Thiazolidinediones
1.2.7 Alpha-glucosidase Inhibitors
1.3 Global Oral Antidiabetic Agents Market by Application
1.3.1 Overview: Global Oral Antidiabetic Agents Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Home Use
1.3.3 Medical Institutions
1.3.4 Others
1.4 Global Oral Antidiabetic Agents Market Size & Forecast
1.5 Global Oral Antidiabetic Agents Market Size and Forecast by Region
1.5.1 Global Oral Antidiabetic Agents Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Oral Antidiabetic Agents Market Size by Region, (2016-2021)
1.5.3 North America Oral Antidiabetic Agents Market Size and Prospect (2016-2026)
1.5.4 Europe Oral Antidiabetic Agents Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Oral Antidiabetic Agents Market Size and Prospect (2016-2026)
1.5.6 South America Oral Antidiabetic Agents Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Oral Antidiabetic Agents Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Oral Antidiabetic Agents Market Drivers
1.6.2 Oral Antidiabetic Agents Market Restraints
1.6.3 Oral Antidiabetic Agents Trends Analysis
2 Company Profiles
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk Oral Antidiabetic Agents Product and Solutions
2.1.4 Novo Nordisk Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Novo Nordisk Recent Developments and Future Plans
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly Oral Antidiabetic Agents Product and Solutions
2.2.4 Eli Lilly Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Eli Lilly Recent Developments and Future Plans
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Oral Antidiabetic Agents Product and Solutions
2.3.4 Sanofi Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Sanofi Recent Developments and Future Plans
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Oral Antidiabetic Agents Product and Solutions
2.4.4 Roche Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Roche Recent Developments and Future Plans
2.5 Teva
2.5.1 Teva Details
2.5.2 Teva Major Business
2.5.3 Teva Oral Antidiabetic Agents Product and Solutions
2.5.4 Teva Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Teva Recent Developments and Future Plans
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Oral Antidiabetic Agents Product and Solutions
2.6.4 AstraZeneca Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 AstraZeneca Recent Developments and Future Plans
2.7 Wockhardt UK
2.7.1 Wockhardt UK Details
2.7.2 Wockhardt UK Major Business
2.7.3 Wockhardt UK Oral Antidiabetic Agents Product and Solutions
2.7.4 Wockhardt UK Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Wockhardt UK Recent Developments and Future Plans
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Oral Antidiabetic Agents Product and Solutions
2.8.4 Merck Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Merck Recent Developments and Future Plans
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Oral Antidiabetic Agents Product and Solutions
2.9.4 Pfizer Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Pfizer Recent Developments and Future Plans
2.10 Cipla
2.10.1 Cipla Details
2.10.2 Cipla Major Business
2.10.3 Cipla Oral Antidiabetic Agents Product and Solutions
2.10.4 Cipla Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Cipla Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Oral Antidiabetic Agents Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Oral Antidiabetic Agents Players Market Share
3.2.2 Top 10 Oral Antidiabetic Agents Players Market Share
3.2.3 Market Competition Trend
3.3 Oral Antidiabetic Agents Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Oral Antidiabetic Agents Revenue and Market Share by Type (2016-2021)
4.2 Global Oral Antidiabetic Agents Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Oral Antidiabetic Agents Revenue Market Share by Application (2016-2021)
5.2 Oral Antidiabetic Agents Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Oral Antidiabetic Agents Revenue by Type (2016-2026)
6.2 North America Oral Antidiabetic Agents Revenue by Application (2016-2026)
6.3 North America Oral Antidiabetic Agents Market Size by Country
6.3.1 North America Oral Antidiabetic Agents Revenue by Country (2016-2026)
6.3.2 United States Oral Antidiabetic Agents Market Size and Forecast (2016-2026)
6.3.3 Canada Oral Antidiabetic Agents Market Size and Forecast (2016-2026)
6.3.4 Mexico Oral Antidiabetic Agents Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Oral Antidiabetic Agents Revenue by Type (2016-2026)
7.2 Europe Oral Antidiabetic Agents Revenue by Application (2016-2026)
7.3 Europe Oral Antidiabetic Agents Market Size by Country
7.3.1 Europe Oral Antidiabetic Agents Revenue by Country (2016-2026)
7.3.2 Germany Oral Antidiabetic Agents Market Size and Forecast (2016-2026)
7.3.3 France Oral Antidiabetic Agents Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Oral Antidiabetic Agents Market Size and Forecast (2016-2026)
7.3.5 Russia Oral Antidiabetic Agents Market Size and Forecast (2016-2026)
7.3.6 Italy Oral Antidiabetic Agents Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Oral Antidiabetic Agents Revenue by Type (2016-2026)
8.2 Asia-Pacific Oral Antidiabetic Agents Revenue by Application (2016-2026)
8.3 Asia-Pacific Oral Antidiabetic Agents Market Size by Region
8.3.1 Asia-Pacific Oral Antidiabetic Agents Revenue by Region (2016-2026)
8.3.2 China Oral Antidiabetic Agents Market Size and Forecast (2016-2026)
8.3.3 Japan Oral Antidiabetic Agents Market Size and Forecast (2016-2026)
8.3.4 South Korea Oral Antidiabetic Agents Market Size and Forecast (2016-2026)
8.3.5 India Oral Antidiabetic Agents Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Oral Antidiabetic Agents Market Size and Forecast (2016-2026)
8.3.7 Australia Oral Antidiabetic Agents Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Oral Antidiabetic Agents Revenue by Type (2016-2026)
9.2 South America Oral Antidiabetic Agents Revenue by Application (2016-2026)
9.3 South America Oral Antidiabetic Agents Market Size by Country
9.3.1 South America Oral Antidiabetic Agents Revenue by Country (2016-2026)
9.3.2 Brazil Oral Antidiabetic Agents Market Size and Forecast (2016-2026)
9.3.3 Argentina Oral Antidiabetic Agents Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Oral Antidiabetic Agents Revenue by Type (2016-2026)
10.2 Middle East & Africa Oral Antidiabetic Agents Revenue by Application (2016-2026)
10.3 Middle East & Africa Oral Antidiabetic Agents Market Size by Country
10.3.1 Middle East & Africa Oral Antidiabetic Agents Revenue by Country (2016-2026)
10.3.2 Turkey Oral Antidiabetic Agents Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Oral Antidiabetic Agents Market Size and Forecast (2016-2026)
10.3.4 UAE Oral Antidiabetic Agents Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Oral Antidiabetic Agents Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Oral Antidiabetic Agents Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Oral Antidiabetic Agents Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Oral Antidiabetic Agents Revenue (USD Million) by Region (2016-2021)
Table 5. Global Oral Antidiabetic Agents Revenue Market Share by Region (2021-2026)
Table 6. Novo Nordisk Corporate Information, Head Office, and Major Competitors
Table 7. Novo Nordisk Major Business
Table 8. Novo Nordisk Oral Antidiabetic Agents Product and Solutions
Table 9. Novo Nordisk Oral Antidiabetic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 11. Eli Lilly Major Business
Table 12. Eli Lilly Oral Antidiabetic Agents Product and Solutions
Table 13. Eli Lilly Oral Antidiabetic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Sanofi Corporate Information, Head Office, and Major Competitors
Table 15. Sanofi Major Business
Table 16. Sanofi Oral Antidiabetic Agents Product and Solutions
Table 17. Sanofi Oral Antidiabetic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Roche Corporate Information, Head Office, and Major Competitors
Table 19. Roche Major Business
Table 20. Roche Oral Antidiabetic Agents Product and Solutions
Table 21. Roche Oral Antidiabetic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Teva Corporate Information, Head Office, and Major Competitors
Table 23. Teva Major Business
Table 24. Teva Oral Antidiabetic Agents Product and Solutions
Table 25. Teva Oral Antidiabetic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 27. AstraZeneca Major Business
Table 28. AstraZeneca Oral Antidiabetic Agents Product and Solutions
Table 29. AstraZeneca Oral Antidiabetic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Wockhardt UK Corporate Information, Head Office, and Major Competitors
Table 31. Wockhardt UK Major Business
Table 32. Wockhardt UK Oral Antidiabetic Agents Product and Solutions
Table 33. Wockhardt UK Oral Antidiabetic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Merck Corporate Information, Head Office, and Major Competitors
Table 35. Merck Major Business
Table 36. Merck Oral Antidiabetic Agents Product and Solutions
Table 37. Merck Oral Antidiabetic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Pfizer Corporate Information, Head Office, and Major Competitors
Table 39. Pfizer Major Business
Table 40. Pfizer Oral Antidiabetic Agents Product and Solutions
Table 41. Pfizer Oral Antidiabetic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Cipla Corporate Information, Head Office, and Major Competitors
Table 43. Cipla Major Business
Table 44. Cipla Oral Antidiabetic Agents Product and Solutions
Table 45. Cipla Oral Antidiabetic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Oral Antidiabetic Agents Revenue (USD Million) by Players (2019-2021)
Table 47. Global Oral Antidiabetic Agents Revenue Share by Players (2019-2021)
Table 48. Breakdown of Oral Antidiabetic Agents by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Oral Antidiabetic Agents Players Head Office, Products and Services Provided
Table 50. Oral Antidiabetic Agents Mergers & Acquisitions in the Past Five Years
Table 51. Oral Antidiabetic Agents New Entrants and Expansion Plans
Table 52. Global Oral Antidiabetic Agents Revenue (USD Million) by Type (2016-2021)
Table 53. Global Oral Antidiabetic Agents Revenue Share by Type (2016-2021)
Table 54. Global Oral Antidiabetic Agents Revenue Forecast by Type (2021-2026)
Table 55. Global Oral Antidiabetic Agents Revenue by Application (2016-2021)
Table 56. Global Oral Antidiabetic Agents Revenue Forecast by Application (2021-2026)
Table 57. North America Oral Antidiabetic Agents Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Oral Antidiabetic Agents Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Oral Antidiabetic Agents Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Oral Antidiabetic Agents Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Oral Antidiabetic Agents Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Oral Antidiabetic Agents Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Oral Antidiabetic Agents Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Oral Antidiabetic Agents Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Oral Antidiabetic Agents Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Oral Antidiabetic Agents Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Oral Antidiabetic Agents Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Oral Antidiabetic Agents Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Oral Antidiabetic Agents Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Oral Antidiabetic Agents Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Oral Antidiabetic Agents Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Oral Antidiabetic Agents Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Oral Antidiabetic Agents Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Oral Antidiabetic Agents Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Oral Antidiabetic Agents Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Oral Antidiabetic Agents Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Oral Antidiabetic Agents Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Oral Antidiabetic Agents Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Oral Antidiabetic Agents Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Oral Antidiabetic Agents Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Oral Antidiabetic Agents Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Oral Antidiabetic Agents Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Oral Antidiabetic Agents Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Oral Antidiabetic Agents Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Oral Antidiabetic Agents Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Oral Antidiabetic Agents Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Oral Antidiabetic Agents Picture
Figure 2. Global Oral Antidiabetic Agents Revenue Market Share by Type in 2020
Figure 3. Sulfonylureas
Figure 4. Meglitinides
Figure 5. Biguanides
Figure 6. Thiazolidinediones
Figure 7. Alpha-glucosidase Inhibitors
Figure 8. Oral Antidiabetic Agents Revenue Market Share by Application in 2020
Figure 9. Home Use Picture
Figure 10. Medical Institutions Picture
Figure 11. Others Picture
Figure 12. Global Oral Antidiabetic Agents Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Oral Antidiabetic Agents Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Oral Antidiabetic Agents Revenue Market Share by Region (2016-2026)
Figure 15. Global Oral Antidiabetic Agents Revenue Market Share by Region in 2020
Figure 16. North America Oral Antidiabetic Agents Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Oral Antidiabetic Agents Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Oral Antidiabetic Agents Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Oral Antidiabetic Agents Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Oral Antidiabetic Agents Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Oral Antidiabetic Agents Market Drivers
Figure 22. Oral Antidiabetic Agents Market Restraints
Figure 23. Oral Antidiabetic Agents Market Trends
Figure 24. Novo Nordisk Recent Developments and Future Plans
Figure 25. Eli Lilly Recent Developments and Future Plans
Figure 26. Sanofi Recent Developments and Future Plans
Figure 27. Roche Recent Developments and Future Plans
Figure 28. Teva Recent Developments and Future Plans
Figure 29. AstraZeneca Recent Developments and Future Plans
Figure 30. Wockhardt UK Recent Developments and Future Plans
Figure 31. Merck Recent Developments and Future Plans
Figure 32. Pfizer Recent Developments and Future Plans
Figure 33. Cipla Recent Developments and Future Plans
Figure 34. Global Oral Antidiabetic Agents Revenue Share by Players in 2020
Figure 35. Oral Antidiabetic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players Oral Antidiabetic Agents Revenue Market Share in 2020
Figure 37. Global Top 10 Players Oral Antidiabetic Agents Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global Oral Antidiabetic Agents Revenue Share by Type in 2020
Figure 40. Global Oral Antidiabetic Agents Market Share Forecast by Type (2021-2026)
Figure 41. Global Oral Antidiabetic Agents Revenue Share by Application in 2020
Figure 42. Global Oral Antidiabetic Agents Market Share Forecast by Application (2021-2026)
Figure 43. North America Oral Antidiabetic Agents Sales Market Share by Type (2016-2026)
Figure 44. North America Oral Antidiabetic Agents Sales Market Share by Application (2016-2026)
Figure 45. North America Oral Antidiabetic Agents Revenue Market Share by Country (2016-2026)
Figure 46. United States Oral Antidiabetic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Oral Antidiabetic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Oral Antidiabetic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Oral Antidiabetic Agents Sales Market Share by Type (2016-2026)
Figure 50. Europe Oral Antidiabetic Agents Sales Market Share by Application (2016-2026)
Figure 51. Europe Oral Antidiabetic Agents Revenue Market Share by Country (2016-2026)
Figure 52. Germany Oral Antidiabetic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Oral Antidiabetic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Oral Antidiabetic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Oral Antidiabetic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Oral Antidiabetic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Oral Antidiabetic Agents Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific Oral Antidiabetic Agents Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Oral Antidiabetic Agents Revenue Market Share by Region (2016-2026)
Figure 60. China Oral Antidiabetic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Oral Antidiabetic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea Oral Antidiabetic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Oral Antidiabetic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Oral Antidiabetic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Oral Antidiabetic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Oral Antidiabetic Agents Sales Market Share by Type (2016-2026)
Figure 67. South America Oral Antidiabetic Agents Sales Market Share by Application (2016-2026)
Figure 68. South America Oral Antidiabetic Agents Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Oral Antidiabetic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Oral Antidiabetic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa Oral Antidiabetic Agents Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa Oral Antidiabetic Agents Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa Oral Antidiabetic Agents Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Oral Antidiabetic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Oral Antidiabetic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE Oral Antidiabetic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source


【掲載企業】

Novo Nordisk、Eli Lilly、Sanofi、Roche、Teva、AstraZeneca、Wockhardt UK、Merck、Pfizer、Cipla

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の経口糖尿病治療薬市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)(Global Oral Antidiabetic Agents Market 2021 by Company, Regions, Type and Application, Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。